Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update evaluating SCT-I10A in patients with advanced solid tumors or lymphoma, focusing on safety, tolerability, pharmacokineti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• SCT-I10A

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Advanced Solid Tumors or Lymphoma | Phase 1 | Status: UNKNOWN